Aristotle University Of Thessaloniki (AUTH)
Υπολογισμός καρδιαγγειακού κινδύνου μέσω προσδιορισμού προγνωστικών δεικτών στους φαινότυπους του συνδρόμου των πολυκυστικών ωοθηκών
Abstract
dc:descriptionAim: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women during reproductive age. It is a very heterogeneous condition characterized by irregular menses, hyperandrogenism and/or polycystic ovaries. PCOS may be related to both infertility and increased cardiovascular disease (CVD) risk. The prevalence of PCOS is affected by the definition used for its diagnosis. The National Institutes of Health/National Institute of Child Health and Human Disease (NIH/NICHD) definition, adopted in 1990, suggests a 8% prevalence in women of reproductive age, while the Rotterdam definition adopted in 2003 by the European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine (ESHRE/ASRM) suggests a 15-20% prevalence in women of reproductive age (i.e. about 3 times higher than the 1990 definition). The Rotterdam definition criteria allow the diagnosis of PCOS without the presence of hyperandrogenaemia or clinical hyperandrogenism. On the other hand, the 1992 (NIH/NICHD) definition criteria exclude the diagnosis of PCOS in women with regular menses and subclinical ovulatory dysfunction. However, there is considerable variation in the presentation of PCOS phenotypes according to the 2 definitions involving insulin resistance and hyperinsulinaemia that leads to increased risk of dyslipidaemia, metabolic syndrome, type 2 diabetes mellitus (T2DM) and CVD. Therefore the present study was designed with the aim to assess the potential differences in the metabolic and cardiovascular disease (CVD) risk between the distinct phenotypes of the Polycystic Ovary Syndrome (PCOS) according to the Rotterdam definition regardless of age and body mass index (BMI).Patients-Methods: The study included 300 women; 240 women with PCOS, according to the Rotterdam criteria and 60 controls without PCOS. All women were further subdivided, according to their BMI, into normalweight and overweight/obese and PCOS women were furthermore subdivided to the four phenotypes. A complete hormonal and metabolic profile as well as the levels of high sensitivity C reactive protein (hsCRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) were measured.Results: hsCRP levels were higher but without reaching significance in PCOS women compared with controls. In normalweight PCOS patients, Lp-PLA2 levels were significantly higher, compared with lean controls, mainly in the two classic phenotypes. Overweight/obese patients in all four phenotypes had significantly higher Lp-PLA2 levels compared with overweight/obese controls. Evaluated CVD risk according to four risk engines was not different among phenotypes and between PCOS patients and controls. There were several correlations of risk factors with metabolic syndrome and non-alcoholic fatty liver disease requiring appropriate treatment.Conclusions: Only two of the four Rotterdam phenotypes, identical with those of the classic NIH definition (severe PCOS), have excess cardiometabolic risk, especially when combined with obesity. These women need to be treated to prevent CVD events.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Daskalopoulos, Georgios
- Δασκαλόπουλος, Γεώργιος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35652